Michelle Hymowitz

706 total citations
7 papers, 604 citations indexed

About

Michelle Hymowitz is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Michelle Hymowitz has authored 7 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Michelle Hymowitz's work include Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (6 papers) and Signaling Pathways in Disease (3 papers). Michelle Hymowitz is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (6 papers) and Signaling Pathways in Disease (3 papers). Michelle Hymowitz collaborates with scholars based in United States. Michelle Hymowitz's co-authors include Stanley Zucker, Cathleen Conner, Jian Cao, Adam Hurewitz, Hussein D. Foda, David C. Tompkins, Richard H. Mann, Ellen E. Rollo, Bryan P. Toole and Douglas D. Boyd and has published in prestigious journals such as Journal of Biological Chemistry, Annals of the New York Academy of Sciences and American Journal Of Pathology.

In The Last Decade

Michelle Hymowitz

7 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Hymowitz United States	7	327	306	305	112	79	7	604
Rosemarie Chirco United States	4	320 1.0×	237 0.8×	310 1.0×	91 0.8×	90 1.1×	4	662
Michelle D. Martin United States	9	375 1.1×	499 1.6×	348 1.1×	63 0.6×	67 0.8×	14	796
Maria C. Melander Denmark	13	201 0.6×	215 0.7×	175 0.6×	102 0.9×	40 0.5×	18	584
Heath B. Acuff United States	6	259 0.8×	359 1.2×	243 0.8×	101 0.9×	45 0.6×	6	576
Pernille A. Usher Denmark	11	215 0.7×	142 0.5×	152 0.5×	75 0.7×	77 1.0×	14	423
Antonio Cardesa Spain	9	179 0.5×	338 1.1×	337 1.1×	38 0.3×	67 0.8×	10	693
Yvette van Hensbergen Netherlands	12	155 0.5×	348 1.1×	301 1.0×	129 1.2×	132 1.7×	22	666
Iker Antón Spain	9	214 0.7×	225 0.7×	305 1.0×	49 0.4×	39 0.5×	15	538
Karmele Valencia Spain	16	310 0.9×	265 0.9×	445 1.5×	106 0.9×	34 0.4×	29	775

Countries citing papers authored by Michelle Hymowitz

Since Specialization

Citations

This map shows the geographic impact of Michelle Hymowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Hymowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Hymowitz more than expected).

Fields of papers citing papers by Michelle Hymowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Hymowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Hymowitz. The network helps show where Michelle Hymowitz may publish in the future.

Co-authorship network of co-authors of Michelle Hymowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Hymowitz. A scholar is included among the top collaborators of Michelle Hymowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Hymowitz. Michelle Hymowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Zucker, Stanley, Michelle Hymowitz, Cathleen Conner, Yves A. DeClerck, & Jian Cao. (2003). TIMP-2 is released as an intact molecule following binding to MT1-MMP on the cell surface. Experimental Cell Research. 293(1). 164–174. 26 indexed citations

Susskind, H., Michelle Hymowitz, Y.H. Lau, et al.. (2003). Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1161–1169. 33 indexed citations

Zucker, Stanley, et al.. (2002). Rapid Trafficking of Membrane Type 1-Matrix Metalloproteinase to the Cell Surface Regulates Progelatinase A Activation. Laboratory Investigation. 82(12). 1673–1684. 60 indexed citations

Pavlaki, Maria, Jian Cao, Michelle Hymowitz, et al.. (2002). A Conserved Sequence within the Propeptide Domain of Membrane Type 1 Matrix Metalloproteinase Is Critical for Function as an Intramolecular Chaperone. Journal of Biological Chemistry. 277(4). 2740–2749. 23 indexed citations

Zucker, Stanley, Michelle Hymowitz, Ellen E. Rollo, et al.. (2001). Tumorigenic Potential of Extracellular Matrix Metalloproteinase Inducer. American Journal Of Pathology. 158(6). 1921–1928. 228 indexed citations

Cao, Jian, Michelle Hymowitz, Cathleen Conner, Wadie F. Bahou, & Stanley Zucker. (2000). The Propeptide Domain of Membrane Type 1-Matrix Metalloproteinase Acts as an Intramolecular Chaperone when Expressed in transwith the Mature Sequence in COS-1 Cells. Journal of Biological Chemistry. 275(38). 29648–29653. 38 indexed citations

Zucker, Stanley, Michelle Hymowitz, Cathleen Conner, et al.. (1999). Measurement of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Blood and Tissues: Clinical and Experimental Applications. Annals of the New York Academy of Sciences. 878(1). 212–227. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact